In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Compass Therapeutics Inc (NASDAQ: CMPX) closed at $2.90 in the last session, down -0.68% from day before closing price of $2.92. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 0.68 million shares were traded.
Ratios:
We take a closer look at CMPX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.96 and its Current Ratio is at 14.96. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On February 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.
On December 23, 2024, D. Boral Capital started tracking the stock assigning a Buy rating and target price of $32.D. Boral Capital initiated its Buy rating on December 23, 2024, with a $32 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 471.79 while its Price-to-Book (P/B) ratio in mrq is 3.19.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 15.36%, while the 200-Day Moving Average is calculated to be 70.85%.
Shares Statistics:
A total of 137.82M shares are outstanding, with a floating share count of 80.70M. Insiders hold about 41.64% of the company’s shares, while institutions hold 38.88% stake in the company.
